Cited by 377Gut microbiota and healthAdipokines, Inflammation, and Metabolic DiseasesOral microbiology and periodontitis research

Interplay between obesity and associated metabolic disorders: New insights into the gut microbiota

Cani, Patrice D, Delzenne, Nathalie M·2009·Current Opinion in Pharmacology

Abstract

Obesity and associated metabolic disorders are worldwide epidemic. The literature provides new evidence that gut microbiota dysbiosis (at the phyla, genus, or species level) affects host metabolism and energy storage. Here we discuss new findings that may explain how gut microbiota can be involved in the development or in the control of obesity and associated low-grade inflammation. New powerful molecular biology methods and the use of gnotobiotic animal allowed to analyze the molecular link between gut bacteria and the host. Moreover, even if more studies are needed to unravel how changing gut microbiota impacts on the development of obesity and related metabolic alterations, probiotic and prebiotic approach appear as potential interesting treatments to reverse host metabolic alterations linked to gut microbiota dysbiosis.

Integrity signals

Registry

Crossref · 10.1016/j.coph.2009.06.016

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cani, P. D., & Delzenne, N. M.
Affiliations
UCLouvain (BE)
Corresponding author
Cani, Patrice D
Venue
Current Opinion in Pharmacology
Publisher
Elsevier BV
Published
2009-12
Volume
9
Issue
6
Pages
737-743
ISSN
1471-4892 (ISSN-L)
OpenAlex
W1982319117
Cited by
377
References
47
Citations by year
2026: 5 · 2025: 12 · 2024: 11 · 2023: 16 · 2022: 19 · 2021: 16 · 2020: 20 · 2019: 30 · 2018: 20 · 2017: 22 · 2016: 19 · 2015: 32 · 2014: 35 · 2013: 31 · 2012: 30
FWCI
11.80
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • DIAL (Catholic University of Leuven) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
obesity, gut microbiota, dysbiosis, metabolic disorders, low-grade inflammation, energy storage, host metabolism, gnotobiotic animals, probiotics, prebiotics, microbiota-host interactions
MeSH terms
Animals, Bifidobacterium, Homeostasis, Humans, Inflammation, Models, Biological, Obesity, Drug Delivery Systems, Mice, Knockout, Probiotics, Metabolic Syndrome, Gastrointestinal Tract, Mice, Metagenome, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review